Phased array magnetic resonance imaging for staging clinically localized prostate cancer

Acta Oncologica

Volumn 44, Issue 6, 2005, Pages 589-592

  Borre, Michael ^a   Lundorf, Erik ^a   Marcussen, Niels ^a   Langkilde, Niels Christian ^a   Wolf, Hans ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGIST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; TUMOR BIOPSY;

EID: 27144507443     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Fibiger J, Trier S. Bericht über die Zählung der am 1. April 1908 in Dänemark in ärztlicher Behandlung gewesenen Krebskranken. Zeitschrift für Krebsforschung 1910;9:275-337.
2. Clemmensen IH, Storm HH. Kræft i Danmark. København: Kræftens Bekæmpelse; 1993.
3. Borre M, Nerstrøm B, Overgaard J. The dilemma of prostate cancer: A growing human and economical burden irrespective of treatment strategies. Acta Oncol 1997;36:681-7.
4. Walsh PC. Prostate cancer kills: Strategy to reduce deaths. Urology 1994;44:463-6.
5. Nilsson S, Norlén BJ, Widmark A. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 2004;43:316-81.
6. Pedersen KV, Herder A. A radical retropubic prostatectomy for localized prostatic carcinoma: a clinical and pathological study of 201 cases. Scand J Urol Nephrol 1993;27:219-24.
7. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167: 528-34.
8. Lorentzen T, Nerstøm H, Iversen P, Torp-Pedersen ST. Local staging of prostate cancer with transrectal ultrasound: a literature review. Prostate Suppl 1992;4:11-6.
9. Ohori M, Wheeler TM, Scardino PT. The new American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Cancer 1994;74:104-10.
10. Yu KK, Hricak H. Imaging prostate cancer. Radiol Clin North Am 2000;38:59-85.
11. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, et al. Radiology 1994;193:703-9.
12. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195:385-90.
13. Yu KK, Scheidler J, Hricak J, Vigneron DB, Males RG, Nelson SJ, et al. Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiol 1999;213:481-8.
14. Wallner K. MR imaging for prostate cancer staging: Beauty or beast. Int J Radiation Oncology Biol Phys 2002;52: 886-7.
15. May F, Treumann T, Dettmar P, Hartung R, Breul J. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 2001;87:66-9.
16. Engelbrecht MR, Gerrit JJ, Laheij RJ, Verbeek ALM, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis. Eur Radiol 2002;12:2294-302.
17. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002;16:451-63.